Knockdown of TACC3 inhibits tumor cell proliferation and increases chemosensitivity in pancreatic cancer

Abstract Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant digestive tract tumor with limited clinical treatments. Transforming acidic coiled-coil-containing protein 3 (TACC3) is a component of the centrosome axis and a member of the TACC family, which affect mitosis and regulate chromos...

Full description

Bibliographic Details
Main Authors: Saimeng Shi, Duancheng Guo, Longyun Ye, Tianjiao Li, Qinglin Fei, Mengxiong Lin, Xianjun Yu, Kaizhou Jin, Weiding Wu
Format: Article
Language:English
Published: Nature Publishing Group 2023-11-01
Series:Cell Death and Disease
Online Access:https://doi.org/10.1038/s41419-023-06313-x
_version_ 1827602717119348736
author Saimeng Shi
Duancheng Guo
Longyun Ye
Tianjiao Li
Qinglin Fei
Mengxiong Lin
Xianjun Yu
Kaizhou Jin
Weiding Wu
author_facet Saimeng Shi
Duancheng Guo
Longyun Ye
Tianjiao Li
Qinglin Fei
Mengxiong Lin
Xianjun Yu
Kaizhou Jin
Weiding Wu
author_sort Saimeng Shi
collection DOAJ
description Abstract Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant digestive tract tumor with limited clinical treatments. Transforming acidic coiled-coil-containing protein 3 (TACC3) is a component of the centrosome axis and a member of the TACC family, which affect mitosis and regulate chromosome stability and are involved in tumor development and progression. However, the role of TACC3 in PDAC remains elusive. In this study, by exploiting the TCGA database, we found that high TACC3 expression in PDAC is associated with poor prognosis. shRNA-mediated TACC3 knockdown caused S phase arrest of the cell cycle and inhibited proliferation in PDAC cell lines. Through RNA sequencing and protein co-immunoprecipitation combined with mass spectrometry, KIF11 was identified as a protein that interacts with TACC3. TACC3 stabilizes and regulates KIF11 protein expression levels in PDAC cells through physical interaction. Knockdown of TACC3 or KIF11 resulted in abnormal spindle formation during cell division both in vitro and in vivo. Pharmacological inhibition of TACC3 or KIF11 can suppress tumor cell proliferation and promote apoptosis. Our studies further demonstrated that high expression of TACC3 and KIF11 mediated the resistance of PDAC to gemcitabine, and deficiency of TACC3 or KIF11 increased the sensitivity of PDAC cells to chemotherapy. In conclusion, our study reveals the fundamental role of TACC3 expression in PDAC cell proliferation and chemoresistance, suggesting that TACC3 can be used as a molecular marker to evaluate the prognosis of PDAC.
first_indexed 2024-03-09T05:24:29Z
format Article
id doaj.art-9a85e684f5cb4e558f07329aad902170
institution Directory Open Access Journal
issn 2041-4889
language English
last_indexed 2024-03-09T05:24:29Z
publishDate 2023-11-01
publisher Nature Publishing Group
record_format Article
series Cell Death and Disease
spelling doaj.art-9a85e684f5cb4e558f07329aad9021702023-12-03T12:38:10ZengNature Publishing GroupCell Death and Disease2041-48892023-11-01141111810.1038/s41419-023-06313-xKnockdown of TACC3 inhibits tumor cell proliferation and increases chemosensitivity in pancreatic cancerSaimeng Shi0Duancheng Guo1Longyun Ye2Tianjiao Li3Qinglin Fei4Mengxiong Lin5Xianjun Yu6Kaizhou Jin7Weiding Wu8Department of Pancreatic Surgery, Fudan University Shanghai Cancer CenterDepartment of Pancreatic Surgery, Fudan University Shanghai Cancer CenterDepartment of Pancreatic Surgery, Fudan University Shanghai Cancer CenterDepartment of Pancreatic Surgery, Fudan University Shanghai Cancer CenterDepartment of Pancreatic Surgery, Fudan University Shanghai Cancer CenterDepartment of Pancreatic Surgery, Fudan University Shanghai Cancer CenterDepartment of Pancreatic Surgery, Fudan University Shanghai Cancer CenterDepartment of Pancreatic Surgery, Fudan University Shanghai Cancer CenterDepartment of Pancreatic Surgery, Fudan University Shanghai Cancer CenterAbstract Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant digestive tract tumor with limited clinical treatments. Transforming acidic coiled-coil-containing protein 3 (TACC3) is a component of the centrosome axis and a member of the TACC family, which affect mitosis and regulate chromosome stability and are involved in tumor development and progression. However, the role of TACC3 in PDAC remains elusive. In this study, by exploiting the TCGA database, we found that high TACC3 expression in PDAC is associated with poor prognosis. shRNA-mediated TACC3 knockdown caused S phase arrest of the cell cycle and inhibited proliferation in PDAC cell lines. Through RNA sequencing and protein co-immunoprecipitation combined with mass spectrometry, KIF11 was identified as a protein that interacts with TACC3. TACC3 stabilizes and regulates KIF11 protein expression levels in PDAC cells through physical interaction. Knockdown of TACC3 or KIF11 resulted in abnormal spindle formation during cell division both in vitro and in vivo. Pharmacological inhibition of TACC3 or KIF11 can suppress tumor cell proliferation and promote apoptosis. Our studies further demonstrated that high expression of TACC3 and KIF11 mediated the resistance of PDAC to gemcitabine, and deficiency of TACC3 or KIF11 increased the sensitivity of PDAC cells to chemotherapy. In conclusion, our study reveals the fundamental role of TACC3 expression in PDAC cell proliferation and chemoresistance, suggesting that TACC3 can be used as a molecular marker to evaluate the prognosis of PDAC.https://doi.org/10.1038/s41419-023-06313-x
spellingShingle Saimeng Shi
Duancheng Guo
Longyun Ye
Tianjiao Li
Qinglin Fei
Mengxiong Lin
Xianjun Yu
Kaizhou Jin
Weiding Wu
Knockdown of TACC3 inhibits tumor cell proliferation and increases chemosensitivity in pancreatic cancer
Cell Death and Disease
title Knockdown of TACC3 inhibits tumor cell proliferation and increases chemosensitivity in pancreatic cancer
title_full Knockdown of TACC3 inhibits tumor cell proliferation and increases chemosensitivity in pancreatic cancer
title_fullStr Knockdown of TACC3 inhibits tumor cell proliferation and increases chemosensitivity in pancreatic cancer
title_full_unstemmed Knockdown of TACC3 inhibits tumor cell proliferation and increases chemosensitivity in pancreatic cancer
title_short Knockdown of TACC3 inhibits tumor cell proliferation and increases chemosensitivity in pancreatic cancer
title_sort knockdown of tacc3 inhibits tumor cell proliferation and increases chemosensitivity in pancreatic cancer
url https://doi.org/10.1038/s41419-023-06313-x
work_keys_str_mv AT saimengshi knockdownoftacc3inhibitstumorcellproliferationandincreaseschemosensitivityinpancreaticcancer
AT duanchengguo knockdownoftacc3inhibitstumorcellproliferationandincreaseschemosensitivityinpancreaticcancer
AT longyunye knockdownoftacc3inhibitstumorcellproliferationandincreaseschemosensitivityinpancreaticcancer
AT tianjiaoli knockdownoftacc3inhibitstumorcellproliferationandincreaseschemosensitivityinpancreaticcancer
AT qinglinfei knockdownoftacc3inhibitstumorcellproliferationandincreaseschemosensitivityinpancreaticcancer
AT mengxionglin knockdownoftacc3inhibitstumorcellproliferationandincreaseschemosensitivityinpancreaticcancer
AT xianjunyu knockdownoftacc3inhibitstumorcellproliferationandincreaseschemosensitivityinpancreaticcancer
AT kaizhoujin knockdownoftacc3inhibitstumorcellproliferationandincreaseschemosensitivityinpancreaticcancer
AT weidingwu knockdownoftacc3inhibitstumorcellproliferationandincreaseschemosensitivityinpancreaticcancer